Female breast ptosis is a consequence of aging. Polydioxanone thread lift (PDOT) for breast ptosis offers an alternative to those not desirous of surgery and can also be used as an add-on treatment after surgery for finer correction. This week, we review article on Absorbable Thread Lift in Breast Ptosis.
An ideal esthetic nipple lies between 5 and 7cm above the inferior mammary crease in a non-augmented breast. Progressive resting of the gland against the rib cage reflects ptosis. History of significant (50 lbs.) weight loss, higher body mass index (BMI), larger bra cup size, number of pregnancies, and smoking have been described as the significant risk factors for breast ptosis. It is also one of the most common conditions treated by reconstructive surgeons.
In an article published on J Cutan Aesthet Surg., female patients seeking correction of breast ptosis between January and December 2016 at a dermatology center were selected for management with PDOT (monofilaments, 90mm). Those who were seeking breast volume augmentation, with severe obesity (BMI >40kg/m2), ptosis of grade 3, breast cup size >3, pregnant, and lactating, and those with a history of keloids were excluded.
All selected patients underwent a breast examination to rule out preexisting breast disease, were assessed for degree of ptosis as per Regnault ptosis scale and photographed before and after the procedure, and upon follow-up at 6 months after undergoing PDOT. Preexisting breast disease or any abnormality during the examination was considered contraindication for the procedure.
Eutectic mixture of prilocaine and lidocaine was used as a local anesthetic for a period of 1h prior to PDOT under aseptic precautions. Crosshatch technique was used for upper pole fullness and inferior to nipple areolar complex, overlapping linear threading for lift along vectors directed at an angle against gravity as well as circular insertion in upper pole for firmness and shaping (scaffolding). Post treatment, all were advised a supportive brassiere for 2 weeks. Patients’ response to treatment was also recorded according to visual analog scale (VAS) (4+, >75% improvement; 3+, 50–75% improvement; 2+, 25–50% improvement; 1+, 0–25% improvement; and no response).
Ten female patients underwent PDOT insertion and were followed up till 6 months after procedure. The mean pre-procedure ptosis degree was 2.3 and post-procedure was 0.7 [Table 1]. This was statistically significant (P = 0.0002). Eight cases (80%) were satisfied with the procedure outcome (VAS 3+) and one each achieved VAS 2+ and 1+. All were satisfied with the upper pole fullness. Post-procedure bruising was seen as a sequela. No other complications were observed.
Polydioxanone absorbable threads produce instant result, which improves over the initial few weeks, and may last for up to 2 years. Scaffolding, as elaborated earlier, has not been described earlier in thread lift. It provides a better lift for the larger breast volume and its effect lasts longer, as threads are inserted at an angle to the vertical gravity effect, with crossed threads helping in laying down a collagen matrix. Circumferential insertion ensures upper pole definition. As per our experience, a repeat session is needed after 12–15 months.
PDOT is reported to work by stimulating neo-angiogenesis, collagen stimulation, and fibroblast stimulation, which further improves skin texture. The procedure needs considerable expertise with patient selection, correct vector determination, a correct insertion plane within ligaments of Cooper, and repeat sessions to maintain effect as with other esthetic procedures like botulinum toxin. It is an established treatment modality for face lift and asymmetry correction, with the advantage of a short duration of administration and minimal downtime and discomfort. For these reasons it can also be used for correction of breast ptosis (grade <3), breast asymmetry and used in breast shaping without surgery or general anesthesia. Use of PDOT as a material is justified in breast ptosis, as it is an established suture with high-tensile strength used already in general orthopedic surgery; ocular, gastrointestinal tract, cardiovascular surgery; and general surgery; and gets absorbed in 6 months with no additional suture complication or chance of malignancy.
Learn More about Asian Aesthetic Breast Augmentation with Dr Jae Jin Ock in his Operation Room this coming Sept, 2020:
IFAAS Mini-Fellowship (Observation)
Korean Advanced Aesthetic Breast Augmentation
- Minimal Scarred Breast Augmentation & Breast Lifting
Sept 14-15, 2020
Seoul, South Korea
Faculty: Dr. Jae Jin Ock, S. Korea
More Upcoming Aesthetic Trainings Happening Globally
Global Event Calendar